# A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis

> **NCT03373695** · NA · COMPLETED · sponsor: **DK Medical Technology (Suzhou) Co., Ltd.** · enrollment: 260 (actual)

## Conditions studied

- Coronary In-stent Restenosis

## Interventions

- **DEVICE:** Dissolve™
- **DEVICE:** SeQuent®Please

## Key facts

- **NCT ID:** NCT03373695
- **Lead sponsor:** DK Medical Technology (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-22
- **Primary completion:** 2020-01-09
- **Final completion:** 2024-04-24
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2025-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03373695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03373695, "A Safety and Efficacy Study of Dissolve™ in Treatment of Coronary In-stent Restenosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03373695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*